-
RYTM Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Rhythm Pharmaceuticals (RYTM)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 89.60 mm | 89.60 mm | 89.60 mm | 89.60 mm | 89.60 mm | 89.60 mm |
Cash burn (monthly) | (no burn) | (no burn) | 14.46 mm | 22.41 mm | 6.28 mm | 9.49 mm |
Cash used (since last report) | n/a | n/a | 33.16 mm | 51.39 mm | 14.40 mm | 21.76 mm |
Cash remaining | n/a | n/a | 56.44 mm | 38.21 mm | 75.20 mm | 67.84 mm |
Runway (months of cash) | n/a | n/a | 3.9 | 1.7 | 12.0 | 7.1 |
13F holders | Current |
---|---|
Total holders | 208 |
Opened positions | 53 |
Closed positions | 28 |
Increased positions | 63 |
Reduced positions | 54 |
13F shares | Current |
---|---|
Total value | 3.53 tn |
Total shares | 71.44 mm |
Total puts | 26.60 k |
Total calls | 444.50 k |
Total put/call ratio | 0.1 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 6.95 mm | $389.10 bn |
Primecap Management | 6.57 mm | $367.86 bn |
Ra Capital Management | 6.08 mm | $340.61 bn |
Baker Bros. Advisors | 6.08 mm | $340.60 bn |
Perceptive Advisors | 3.68 mm | $206.03 bn |
Vanguard | 3.44 mm | $192.72 bn |
New Enterprise Associates 13 | 2.91 mm | $70.83 mm |
NEA Management | 2.91 mm | $162.90 bn |
Frazier Life Sciences Management | 1.87 mm | $104.67 bn |
Flynn James E | 1.87 mm | $18.64 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Feb 25 | Pamela J. Cramer | Common Stock | Sell | Dispose S | No | Yes | 57.22 | 982 | 56.19 k | 19,209 |
19 Feb 25 | Jennifer Chien | Common Stock | Sell | Dispose S | No | Yes | 57.22 | 2,035 | 116.44 k | 5,858 |
19 Feb 25 | Christopher Paul German | Common Stock | Sell | Dispose S | No | Yes | 57.22 | 635 | 36.33 k | 2,070 |
16 Feb 25 | Pamela J. Cramer | Common Stock | Option exercise | Acquire M | No | No | 0 | 3,300 | 0.00 | 20,191 |
16 Feb 25 | Pamela J. Cramer | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 3,300 | 0.00 | 9,900 |
16 Feb 25 | Jennifer Chien | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,500 | 0.00 | 7,893 |
16 Feb 25 | Jennifer Chien | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 5,500 | 0.00 | 16,500 |
16 Feb 25 | Christopher Paul German | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,807 | 0.00 | 2,705 |
16 Feb 25 | Christopher Paul German | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,807 | 0.00 | 5,418 |
16 Feb 25 | Yann Mazabraud | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,500 | 0.00 | 40,370 |